Nidus Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.49 M
as on 24-10-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.54 Cr
as on 24-10-2024
- Satisfied Charges ₹ 3.45 Cr
as on 24-10-2024
- Revenue 21.81%
(FY 2023)
- Profit -12.75%
(FY 2023)
- Ebitda -0.70%
(FY 2023)
- Net Worth 8.21%
(FY 2023)
- Total Assets 2.54%
(FY 2023)
About Nidus Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹1.54 Cr. The company has closed loans amounting to ₹3.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajneesh Bansal, Alka Bansal, Sanjay Bansal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239CH2004PTC041578
- Company No.
041578
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nidus Pharma Private Limited offer?
Nidus Pharma Private Limited offers a wide range of products and services, including Ayurvedic, Herbal Oils and Cosmetics, Herbal Skin Care Cosmetics, Common Disease Medicines, Psoriasis Ointment, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Ointment, Anti Infective Drugs & Medicines, Malaria Medicine, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Nidus Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajneesh Bansal  | Director | 26-Apr-2004 | Current |
| Alka Bansal | Director | 07-Jun-2011 | Current |
| Sanjay Bansal | Director | 10-Mar-2015 | Current |
| Prakhar Bansal | Director | 01-Jul-2020 | Current |
| Krati Singhal | Director | 03-Oct-2020 | Current |
Financial Performance of Nidus Pharma.
Nidus Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.81% increase. The company also saw a substantial fall in profitability, with a 12.75% decrease in profit. The company's net worth moved up by a moderate rise of 8.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nidus Pharma?
In 2023, Nidus Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Sep 2023 | ₹1.38 M | Open |
Axis Bank Limited Creation Date: 20 Jul 2023 | ₹1.40 Cr | Open |
Others Creation Date: 13 Dec 2019 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Nidus Pharma?
Nidus Pharma has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nidus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nidus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
